The global prosthetic heart valves market covers the artificial heart valves which are implanted in the hearts of patients suffering from heart valve disease (HVD). This market is expected to reach USD 8.86 billion by 2022 from USD 4.84 billion in 2017, at a CAGR of 12.9% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245407958
Globally, the prosthetic heart valves market is witnessing growth due to factors such as rising geriatric population and the subsequent growth in the prevalence of heart valve disease (HVD), regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves. On the other hand, the high cost of transcatheter aortic valve replacement (TAVR) procedures and the availability of alternative methods for treating HVD are expected to restrain market growth to a certain extent.
Based on the type of valves, the prosthetic heart valves market is segmented into transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to continue to dominate the global prosthetic heart valves market in 2022. The large share of this segment can be attributed to the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements.
In the report, the global prosthetic heart valves market has been analyzed with respect to four major geographies—North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of 55.20% of the global prosthetic heart valves market in 2017 and is projected to register the highest CAGR of 16.1% from 2017 to 2022. Factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are supporting the growth of the North American prosthetic heart valves market.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=245407958
Given the immense opportunities in developing transcatheter heart valves, market leaders and emerging players are increasing their focus in this market segment in order to increase their revenues.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
[email protected]
Prosthetic Heart Valves Market Size, Share, Trend | Industry Report 2022
An artificial heart valve, also known as a prosthetic valve, is a one-way, open valve surgically implanted into an individual's heart to replace a defective valve.
The term "prosthetic heart valves" is sometimes used to describe any one of these valves.
An artificial heart valve may be made of a variety of materials.
These include surgical grade silicone, saline, or neovascular (stem cells from the heart) valves.
Artificial heart valves may be separated into three general categories mechanical, biocompatible tissue, and synthetic tissue.
Mechanical prosthetic heart valves are most often implanted to treat congenital heart disease.
September 19, 2018: About Prosthetic Heart Valves The prosthetic heart valves are the artificial valves that are made of either metal or animal issue.
These valves mimic the function of the original valves in the patient after the successful implantation.Radiant Insights analysts forecast the Global Prosthetic Heart Valves Market 2018-2022 to grow at a CAGR of 12.38% during the period 2018-2022.Covered in this reportThe report covers the present scenario and the growth prospects of the prosthetic heart valves market.
To calculate the market size, the report considers the revenue generated from the sales of products such as transcatheter heart valves, tissue heart valves, and mechanical heart valves.The market is divided into the following segments based on geography: AmericasAPACEMEATo Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/global-prosthetic-heart-valves-market-2018-2022/request-sampleRadiant Insights report, Global Prosthetic Heart Valves Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts.
The report covers the market landscape and its growth prospects over the coming years.
The report also includes a discussion of the key vendors operating in this market.Key vendors AbbottBoston ScientificEdwards LifesciencesLivaNovaLepu Medical TechnologyMedtronicMarket driverGrowing prevalence of heart-related disordersFor a full, detailed list, view our reportMarket challengeComplications associated with prosthetic heart valve replacementFor a full, detailed list, view our reportMarket trend Emergence of MRI-conditional heart valvesFor a full, detailed list, view our reportKey questions answered in this report What will the market size be in 2022 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?To Browse Full Research Report @: https://www.radiantinsights.com/research/global-prosthetic-heart-valves-market-2018-2022About Radiant Insights:Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process.
The global prosthetic heart valve market was valued at US$ 5,650 Mn in 2015 and is estimated to be valued at US$ 6,304 Mn by 2016, projecting a Y-o-Y growth of 11.6%.
Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.Request a Sample Report with Table of Contents and Figures: http://www.futuremarketinsights.com/reports/sample/rep-gb-666Segmentation highlightsThe global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026.The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015.
Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period.Preview Analysis on Global Prosthetic Heart Valve Market Segmentation By Product Type – Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves; By End User– Hospitals, Ambulatory Surgery Centres: http://www.futuremarketinsights.com/reports/prosthetic-heart-valve-marketRegional market projectionsThe global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA).
The global prosthetic heart valve market is largely prominent in the developed regions.
The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.
UpMarketResearch offers a latest published report on “Global Tissue Heart Valves Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
Tissue Heart Valves market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
September 19, 2018: About Prosthetic Heart Valves The prosthetic heart valves are the artificial valves that are made of either metal or animal issue.
These valves mimic the function of the original valves in the patient after the successful implantation.Radiant Insights analysts forecast the Global Prosthetic Heart Valves Market 2018-2022 to grow at a CAGR of 12.38% during the period 2018-2022.Covered in this reportThe report covers the present scenario and the growth prospects of the prosthetic heart valves market.
To calculate the market size, the report considers the revenue generated from the sales of products such as transcatheter heart valves, tissue heart valves, and mechanical heart valves.The market is divided into the following segments based on geography: AmericasAPACEMEATo Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/global-prosthetic-heart-valves-market-2018-2022/request-sampleRadiant Insights report, Global Prosthetic Heart Valves Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts.
The report covers the market landscape and its growth prospects over the coming years.
The report also includes a discussion of the key vendors operating in this market.Key vendors AbbottBoston ScientificEdwards LifesciencesLivaNovaLepu Medical TechnologyMedtronicMarket driverGrowing prevalence of heart-related disordersFor a full, detailed list, view our reportMarket challengeComplications associated with prosthetic heart valve replacementFor a full, detailed list, view our reportMarket trend Emergence of MRI-conditional heart valvesFor a full, detailed list, view our reportKey questions answered in this report What will the market size be in 2022 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?To Browse Full Research Report @: https://www.radiantinsights.com/research/global-prosthetic-heart-valves-market-2018-2022About Radiant Insights:Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process.
The global prosthetic heart valve market was valued at US$ 5,650 Mn in 2015 and is estimated to be valued at US$ 6,304 Mn by 2016, projecting a Y-o-Y growth of 11.6%.
Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.Request a Sample Report with Table of Contents and Figures: http://www.futuremarketinsights.com/reports/sample/rep-gb-666Segmentation highlightsThe global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026.The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015.
Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period.Preview Analysis on Global Prosthetic Heart Valve Market Segmentation By Product Type – Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves; By End User– Hospitals, Ambulatory Surgery Centres: http://www.futuremarketinsights.com/reports/prosthetic-heart-valve-marketRegional market projectionsThe global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA).
The global prosthetic heart valve market is largely prominent in the developed regions.
The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.
UpMarketResearch offers a latest published report on “Global Tissue Heart Valves Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
Tissue Heart Valves market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
An artificial heart valve, also known as a prosthetic valve, is a one-way, open valve surgically implanted into an individual's heart to replace a defective valve.
The term "prosthetic heart valves" is sometimes used to describe any one of these valves.
An artificial heart valve may be made of a variety of materials.
These include surgical grade silicone, saline, or neovascular (stem cells from the heart) valves.
Artificial heart valves may be separated into three general categories mechanical, biocompatible tissue, and synthetic tissue.
Mechanical prosthetic heart valves are most often implanted to treat congenital heart disease.